M&A Deal Summary |
|
|---|---|
| Date | 2022-08-10 |
| Target | Medsenic |
| Sector | Life Science |
| Buyer(s) | Bone Therapeutics |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2006 |
| Sector | Life Science |
| Employees | 30 |
| Revenue | 1M EUR (2020) |
Bone Therapeutics is an advanced biotechnology company with a unique approach to the development of cell therapy products for bone fracture repair and fracture prevention. It creates a new and unique treatment approach using differentiated bone-forming cells administered via a minimally invasive procedure. Bone Therapeutics was founded in 2006 and is headquartered in Gosselies, Belgium.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: France M&A | 1 of 1 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-10-29 |
Skeletal Cell Therapy Support SA
Charleroi, Belgium Skeletal Cell Therapy Support SA owns and operates a purpose-built CGxP facility of approximately 41,000 square-foot (3,800 square-meter), including its related quality control and product development laboratories, warehouse, grade C, and B cleanrooms and equipment as well as land for further development. Skeletal Cell Therapy Support is based in Charleroi, Belgium. |
Sell | €12M |
